Treatment outcomes and antiretroviral uptake in multidrug-resistant tuberculosis and HIV co-infected patients in Sub Saharan Africa: a systematic review and meta-analysis

被引:48
作者
Chem, Elvis Dzelamonyuy [1 ]
Van Hout, Marie Claire [1 ]
Hope, Vivian [1 ]
机构
[1] Liverpool John Moores Univ, Publ Hlth Inst, Liverpool, Merseyside, England
关键词
Multidrug-resistant tuberculosis; MDR-TB and HIV co-infection; Treatment success; Unsuccessful treatment; Sub Saharan Africa; HIGH TREATMENT SUCCESS; MDR-TB; MANAGEMENT; EUROPE; CARE;
D O I
10.1186/s12879-019-4317-4
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background Multidrug-resistant tuberculosis (MDR-TB) in HIV endemic settings is a major threat to public health. MDR-TB is a substantial and underreported problem in Sub-Saharan Africa (SSA), with recognised cases projected to increase with advancement in diagnostic technology. There is paucity of review evidence on treatment outcomes and antiretroviral (ART) uptake among MDR-TB patients with HIV in SSA. To address this gap a review of treatment outcomes in HIV patients co-infected with MDR-TB in the SSA region was undertaken. Methods Three databases (Medline, Web of Science, CINHAL), Union on Lung Heath conference proceedings and grey literature were searched for publications between January 2004 and May 2018. Records were assessed for eligibility and data extracted. Random effect meta-analysis was conducted using STATA and Cochrane's review manager. Results A total of 271 publications were identified of which nine fulfilled the inclusion criteria. Data was collected from 3368 MDR-TB and HIV co-infected patients from four SSA countries; South Africa (6), Lesotho (1), Botswana (1) and Ethiopia (1). The most common outcome was cure (34.9% cured in the pooled analysis), this was followed by death (18.1% in pooled analysis). ART uptake was high, at 83% in the pooled analysis. Cure ranged from 28.6 to 54.7% among patients on ART and from 22.2 to 57.7% among those not on ART medication. MDR-TB and HIV co-infected patients were less likely to be successfully treated than HIV negative MDR-TB patients (Risk Ratio = 0.87, 95% CI 0.97, 0.96). Conclusion Treatment outcomes for MDR-TB and HIV co-infected patients do not vary widely from those reported globally. However, treatment success was lower among HIV positive MDR-TB patients compared to HIV negative MDR-TB patients. Prompt antiretroviral initiation and interventions to improve treatment adherence are necessary.
引用
收藏
页数:8
相关论文
共 33 条
[1]   Risk factors for poor multidrug-resistant tuberculosis treatment outcomes in Kyiv Oblast, Ukraine [J].
Aibana, Omowunmi ;
Bachmaha, Mariya ;
Krasiuk, Viatcheslav ;
Rybak, Natasha ;
Flanigan, Timothy P. ;
Petrenko, Vasyl ;
Murray, Megan B. .
BMC INFECTIOUS DISEASES, 2017, 17
[2]  
[Anonymous], 2017, MDR
[3]   Improved Survival and Cure Rates With Concurrent Treatment for Multidrug-Resistant Tuberculosis-Human Immunodeficiency Virus Coinfection in South Africa [J].
Brust, James C. M. ;
Shah, N. Sarita ;
Mlisana, Koleka ;
Moodley, Pravi ;
Allana, Salim ;
Campbell, Angela ;
Johnson, Brent A. ;
Master, Iqbal ;
Mthiyane, Thuli ;
Lachman, Simlatha ;
Larkan, Lee-Megan ;
Ning, Yuming ;
Malik, Amyn ;
Smith, Jonathan P. ;
Gandhi, Neel R. .
CLINICAL INFECTIOUS DISEASES, 2018, 66 (08) :1246-1253
[4]   Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB: HIV study [J].
Efsen, A. M. W. ;
Schultze, A. ;
Miller, R. F. ;
Panteleev, A. ;
Skrahin, A. ;
Podlekareva, D. N. ;
Miro, J. M. ;
Girardi, E. ;
Furrer, H. ;
Losso, M. H. ;
Toibaro, J. ;
Cayla, J. A. ;
Mocroft, A. ;
Lundgren, J. D. ;
Post, F. A. ;
Kirk, O. .
JOURNAL OF INFECTION, 2018, 76 (01) :44-54
[5]   Major Challenges in Clinical Management of TB/HIV Coinfected Patients in Eastern Europe Compared with Western Europe and Latin America [J].
Efsen, Anne Marie W. ;
Schultze, Anna ;
Post, Frank A. ;
Panteleev, Alexander ;
Furrer, Hansjakob ;
Miller, Robert F. ;
Losso, Marcelo H. ;
Toibaro, Javier ;
Skrahin, Aliaksandr ;
Miro, Jose M. ;
Cayla, Joan A. ;
Girardi, Enrico ;
Bruyand, Mathias ;
Obel, Niels ;
Podlekareva, Daria N. ;
Lundgren, Jens D. ;
Mocroft, Amanda ;
Kirk, Ole .
PLOS ONE, 2015, 10 (12)
[6]  
Evans D, 2013, SAMJ S AFR MED J, V103, P229, DOI [10.7196/SAMJ.6835, 10.7196/samj.6835]
[7]   Risk factors for multidrug resistant tuberculosis in Europe: a systematic review [J].
Faustini, A ;
Hall, AJ ;
Perucci, CA .
THORAX, 2006, 61 (02) :158-163
[8]   The emerging threat of pre-extensively drug-resistant tuberculosis in West Africa: preparing for large-scale tuberculosis research and drug resistance surveillance [J].
Gehre, Florian ;
Otu, Jacob ;
Kendall, Lindsay ;
Forson, Audrey ;
Kwara, Awewura ;
Kudzawu, Samuel ;
Kehinde, Aderemi O. ;
Adebiyi, Oludele ;
Salako, Kayode ;
Baldeh, Ignatius ;
Jallow, Aisha ;
Jallow, Mamadou ;
Dagnra, Anoumou ;
Disse, Kodjo ;
Kadanga, Essosimna A. ;
Idigbe, Emmanuel Oni ;
Onubogu, Catherine ;
Onyejepu, Nneka ;
Gaye-Diallo, Aissatou ;
Ba-Diallo, Awa ;
Rabna, Paulo ;
Mane, Morto ;
Sanogo, Moumine ;
Diarra, Bassirou ;
Dezemon, Zingue ;
Sanou, Adama ;
Senghore, Madikay ;
Kwambana-Adams, Brenda A. ;
Demba, Edward ;
Faal-Jawara, Tutty ;
Kumar, Samrat ;
Tientcheu, Leopold D. ;
Jallow, Adama ;
Ceesay, Samba ;
Adetifa, Ifedayo ;
Jaye, Assan ;
Pallen, Mark J. ;
D'Alessandro, Umberto ;
Kampmann, Beate ;
Adegbola, Richard A. ;
Mboup, Souleymane ;
Corrah, Tumani ;
de Jong, Bouke C. ;
Antonio, Martin .
BMC MEDICINE, 2016, 14
[9]  
Heller T, 2010, INT J TUBERC LUNG D, V14, P420
[10]   Treatment outcomes for HIV and MDR-TB co-infected adults and children: systematic review and meta-analysis [J].
Isaakidis, P. ;
Casas, E. C. ;
Das, M. ;
Tseretopoulou, X. ;
Ntzani, E. E. ;
Ford, N. .
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2015, 19 (08) :969-978